Recurrent Loss of Heterozygosity Correlates With Clinical Outcome in Pancreatic Neuroendocrine Cancer

npj Genomic Medicine - United Kingdom
doi 10.1038/s41525-018-0058-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Loss of HNF6 Expression Correlates With Human Pancreatic Cancer Progression

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2014English

Loss of Heterozygosity at Chromosome 6q Correlates With Tumor Progression and Patient Survival

International Journal of Oncology
Cancer ResearchOncology
1995English

Sunitinib in Pancreatic Neuroendocrine Tumors. Clinical Case

Medical Council
2019English

Is PTEN Loss Associated With Clinical Outcome Measures in Human Prostate Cancer?

British Journal of Cancer
Cancer ResearchOncology
2008English

Loss of Heterozygosity on Chromosome Arm 16q in Breast Cancer: Clinical, Molecular and Statistical Approaches

Breast Cancer Research
Cancer ResearchOncology
2000English

Expression of Oncogenic BARD1 Isoforms Affects Colon Cancer Progression and Correlates With Clinical Outcome

British Journal of Cancer
Cancer ResearchOncology
2012English

Loss of Heterozygosity on Chromosome 1q in Human Breast Cancer.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

TSC22D1 and PSAP Predict Clinical Outcome of Tamoxifen Treatment in Patients With Recurrent Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2008English

Review of Experiences: Recurrent Pregnancy Loss With Reproductive Outcome in Pregnant Women

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy